---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-028619"
form_type: "8-K"
ticker: "MIRA"
cik: "0001904286"
company_name: "MIRA PHARMACEUTICALS, INC."
filed_at: "2025-12-22T23:59:59+00:00"
generated_at: "2026-05-16T12:27:52.017887+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# MIRA Pharma awards CEO $242K STI, $915K transaction award, and 62,500 PSUs

## Summary
- CEO Erez Aminov receives $242,258 short-term incentive payout for 2025 performance; additional $80,753 contingent on Phase 1 study completion.
- Transaction advisory award of $915,000 approved for negotiating SKNY acquisition; payable in cash, equity, or both at CEO's election.
- 62,500 performance share units issued and immediately vested upon achievement of first market capitalization milestone under LTI plan.

## SEC filing metadata
- accession: 0001493152-25-028619
- form_type: 8-K
- ticker: MIRA
- cik: 0001904286
- company_name: MIRA PHARMACEUTICALS, INC.
- filed_at: 2025-12-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1904286/000149315225028619/0001493152-25-028619-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1904286/000149315225028619/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-028619
- JSON: https://secwatch.observer/filing/0001493152-25-028619.json
- Plain text: https://secwatch.observer/filing/0001493152-25-028619.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.